78 filings
8-K
MNPR
Monopar Therapeutics Inc
16 Apr 24
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
8:00am
8-K
MNPR
Monopar Therapeutics Inc
10 Apr 24
Regulation FD Disclosure
8:00am
8-K
MNPR
Monopar Therapeutics Inc
28 Mar 24
Monopar Reports Fourth Quarter and Full-Year 2023
7:00am
8-K
MNPR
Monopar Therapeutics Inc
7 Mar 24
Regulation FD Disclosure
8:30am
8-K
MNPR
Monopar Therapeutics Inc
5 Mar 24
Monopar Announces Positive Preclinical Therapeutic Isotope Data
7:00am
8-K
70emcoy536 ekp2s8p9j
28 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:45pm
8-K
tscb061va6fe
27 Feb 24
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
6:59am
8-K
q8yj60
22 Feb 24
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
7:00am
8-K
x5b5q6 ko
20 Feb 24
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical
8:00am
8-K
tm67i29
9 Nov 23
Monopar Therapeutics Reports Third Quarter 2023
7:00am
8-K
cplhoz
1 Nov 23
Monopar Presents Data Showing Tumor Reduction Benefit of
7:00am
8-K
4e34vs2li7fn1
30 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
uhgiv93b
10 Aug 23
Monopar Therapeutics Reports Second Quarter 2023
7:00am
8-K
a22x6y41
8 Aug 23
Monopar Provides Encouraging Camsirubicin Clinical Data Update
7:00am
8-K
m1av781
11 Jul 23
Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of Singapore
7:00am
8-K
5k8fq2nrxf rx50i9
28 Jun 23
Submission of Matters to a Vote of Security Holders
4:13pm
8-K
xpa0 14af
1 Jun 23
Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update
7:01am
8-K
nc2q2ped89cup384ig33
11 May 23
Monopar Therapeutics Reports First Quarter 2023
7:03am
8-K
aksnh28qo6b0 gzwoi9
27 Mar 23
Monopar Announces Result of Interim Analysis of Phase 2b/3 VOICE Trial Evaluating Validive for Severe Oral Mucositis
5:01pm
8-K
01nfd
23 Mar 23
Monopar Therapeutics Reports Fourth Quarter and Full-Year 2022
7:03am